Archive for October, 2013

« Previous Entries

Lescol May Help Patients Schedules for Bypass Surgery

Thursday, October 31st, 2013

Lescol (fluvastatin) is part of a group of statins recommended for patients having high ‘bad’ cholesterol levels. A recent study indicates that receiving Lescol or other similar statins before a scheduled bypass surgery may significantly lower the risk of post-surgery complications. Low-density lipoproteins are also called ‘bad’ cholesterol, and it can block the blood flow […]

Epivir-Kaletra Combination As Effective As Triple Drug Therapy

Wednesday, October 30th, 2013

A recent open-label Phase III study shows that a combination therapy with Epivir (lamivudine) and Kaletra (lopinavir-ritonavir) is as effective as the standard triple drug treatment plan for HIV. The standard treatment involves Kaletra with two nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs). This study involved 426 HIV-positive and treatment-naïve patients, and the results were presented at […]

More Customization Key to Bipolar Treatment Effectiveness

Tuesday, October 29th, 2013

A recent trial study suggests that further customization of a bipolar treatment implementation program can improve the patients’ adherence to Life Goals Collaborative Care (LGCC). The study was led by Amy Kilbourne from the University of Michigan Medical School, Ann Arbor. The researchers associated with this study said that the adherence level they noticed was […]

Clinical Score Helps Guide Antibiotic Prescription for Sore Throat

Monday, October 28th, 2013

According to a new study, clinical scores are a good guide for prescribing antibiotics to patients diagnosed with sore throat. They are as effective as rapid streptococcal antigen detection tests or RADTs, which are commonly performed to assess antibiotic dosage. The study was done by Paul Little and colleagues from the University of Southampton, UK. […]

More Powerful Medications Needed for Psoriatic Arthritis

Sunday, October 27th, 2013

A recent study indicates that more powerful medications, when given appropriately and tested for efficacy, can greatly improve the health of patients diagnosed with psoriatic arthritis. The condition is often treated far less aggressively. The study was done by researchers from the University of Leeds, UK, and it involved 182 patients being treated for psoriatic […]

Right Exercise Helps MS Patients

Saturday, October 26th, 2013

A preliminary study suggests that the right exercise options may help improve walking abilities and boost spirits among patients diagnosed with multiple sclerosis (MS). The researchers behind this study suggested that further research is needed to study just how much benefits exercise can provide to MS patients. The study trial was done by researchers from […]

Wellbutrin Approval for Jubilant Life Sciences

Friday, October 25th, 2013

Jubilant Life Sciences, a pharmaceutical company, recently announced that the United States Food and Drug Administration (FDA) gave Abbreviated New Drug Application (ANDA) approval to its bupropion medication. The approval has been given for extended-release tablets of bupropion, which is the generic version of Wellbutrin, manufactured by GlaxoSmithKline. The FDA also approved Jubilant Life Science’s […]

Schizophrenia and Autoimmune Disease Linked

Thursday, October 24th, 2013

A registry-based study recently showed that schizophrenia patients had a greater risk of autoimmune diseases, especially if they got an infection. The study was based on a Danish registry containing data on 3.77 million people, out of which 39,364 were diagnosed with the mental condition. Out of these schizophrenia patients, around 3.6 percent were diagnosed […]

Early Detection of BP with Multifactor Approach

Wednesday, October 23rd, 2013

Preliminary results of the Dresden High-Risk Project point that a multifactorial approach may help doctors diagnose at-risk states for bipolar disease among patients. This study was done by Karolina Leopold an colleagues from the Technische Universität Dresden, Germany. In their report, the researchers say, “[E]arly detection and intervention in patients with [bipolar disorder] provides an […]

Effient Shows Consistent Safety Irrespective of Aspirin Dosage

Tuesday, October 22nd, 2013

New data released from the TRITON-TIMI 38 study suggests that the efficacy and safety of prasugrel (Effient) remains consistent irrespective of the dose of aspirin. The researchers associated with the study also found that the medication had no significant interaction with aspirin. Patients that were given prasugrel post ACS had lower rates of mortality, stroke, […]

« Previous Entries